Sartorius

Gottingen, Germany Founded: 1870 • Age: 156 yrs
Laboratory and biopharmaceutical equipment is developed for production processes.
Annual revenue $4.2B Latest available
Total funding - 7 rounds
Employees 13530 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Sartorius

Sartorius is a company based in Gottingen (Germany) founded in 1870 by Florence Kurth. The company has 13,530 employees as of December 31, 2024. Sartorius has completed 19 acquisitions, including ALS Automated Lab Solutions, Albumedix and AllPure Technologies. Sartorius operates in a competitive market with competitors including Cepheid, Esco Lifesciences, Beckman Coulter, Blackrock Neurotech and Waters Corporation, among others.

  • Headquarter Gottingen, Germany
  • Employees 13530 as on 31 Dec, 2024
  • Founders Florence Kurth
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Sartorius Ag
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.16 B (USD)
    4.66
    as on Dec 31, 2025
  • Net Profit
    $388.57 M (USD)
    293.69
    as on Dec 31, 2025
  • EBITDA
    $1.03 B (USD)
    -0.86
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    13530

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sartorius

Sartorius is a publicly listed company on the EURONEXT with ticker symbol DIM in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: EURONEXT · Ticker: DIM · Sector: Health technology · France

People of Sartorius

Headcount 5000-10000
Employee Profiles 74
Board Members and Advisors 13
Employee Profiles
People
Frank Meyeroltmanns
Marketing Manager
People
René Fáber
Head, Bioprocess Solutions Division
People
Damian Kaminski
Field Account Manager
People
Joachim Kreuzburg
CEO

Unlock access to complete

Board Members and Advisors
people
Lothar Kappich
Chairman
people
Alexandra Gatzemeyer
Board Member

Unlock access to complete

Funding Insights of Sartorius

Investors in Sartorius

Sartorius has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Sartorius

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sartorius

Sartorius has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include ALS Automated Lab Solutions, Albumedix and AllPure Technologies.

Investments
Premium access

Investment portfolio details for Sartorius

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Albumin-based products and technologies for biotherapeutics development are provided.
Locked Locked 2016 Locked
Manufacturer of cell culture systems and consumables for life science applications.
Locked Locked 2012 Locked
Virus quantification technology is developed and supplied by ViroCyt.
Locked Locked 2012 Locked
Premium access

Complete acquisition details for Sartorius

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Sartorius

Premium access

Detailed financials for Sartorius

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sartorius Comparisons

Sartorius Primary company
Description
Laboratory and biopharmaceutical equipment is developed for ...
Location
Gottingen, Germany
Founded Year
1870
Annual Revenue
$4.16 B (USD)
Net Profit
$388.57 M (USD)
EBITDA
$1.03 B (USD)
Employees
13,530
As of 2024
Premium access

Peer comparison for Sartorius

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sartorius

Sartorius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Esco Lifesciences, Beckman Coulter, Blackrock Neurotech and Waters Corporation, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of molecular diagnostic testing solutions
Locked Locked Locked
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
Locked Locked Locked
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
Locked Locked Locked
Medical devices for neurological therapies are developed.
Locked Locked Locked
Provider of laboratory management system for researchers and clinicians
Locked Locked Locked
Instruments for life sciences research and applications are developed.
Premium access

Detailed competitors of Sartorius

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sartorius

Premium access

Complete news archive for Sartorius

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sartorius

Sartorius was founded in 1870 and raised its 1st funding round 144 years after it was founded.

Sartorius is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.

Joachim Kreuzburg is the current CEO of Sartorius.

As of Dec 31, 2024, the latest employee count at Sartorius is 13,530.

Annual revenue of Sartorius is $4.16B as on Dec 31, 2025.

Sartorius was founded in 1870 in Gottingen, Germany, and operates in the biopharmaceutical and laboratory equipment sector. A broad portfolio is offered, covering filtration, fermentation, cell cultivation, and fluid management in biopharmaceutical production. High-tech laboratory equipment, consumables, and advanced bioprocess technology are provided, along with industrial scales. Service, calibration, and verification support are also available to clients globally.

Sartorius's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.

Yes, Sartorius is publicly traded on EURONEXT under the ticker symbol DIM.

Sartorius has made 19 acquisitions, including ALS Automated Lab Solutions, Albumedix, and AllPure Technologies.

Sartorius has 1 investor. Key investors include European Union.

The ticker symbol of Sartorius is DIM on EURONEXT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available